Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Advanced Viral Research completes first part of patient enrollment in phase I trial for diabetes

May 17, 2006

Two-year denosumab efficacy unaffected by weight in postmenopausal women

May 17, 2006

Hypercholesterolemia linked to prostate cancer risk

May 17, 2006

Absence of corneal toxicity suggests naltrexone may be useful for diabetic keratopathy

May 16, 2006

Recent patents describe new diabetic treatment options

May 15, 2006

Vanadium complex with insulin-mimetic activities

May 15, 2006

NephroGenex licenses Pyridorin rights

May 15, 2006

Qnexa produces weight loss in phase II study

May 15, 2006

German report questions therapeutic benefit of Exubera

May 12, 2006

Synthesis and characterization of novel dipeptidyl peptidase IV inhibitors from Pfizer

May 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...